Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Gross Profit (2022 - 2025)

Historic Gross Profit for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $812000.0.

  • Orchestra BioMed Holdings' Gross Profit fell 1164.31% to $812000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 680.52%. This contributed to the annual value of $2.4 million for FY2024, which is 543.9% down from last year.
  • Per Orchestra BioMed Holdings' latest filing, its Gross Profit stood at $812000.0 for Q3 2025, which was down 1164.31% from $790000.0 recorded in Q2 2025.
  • Orchestra BioMed Holdings' 5-year Gross Profit high stood at $1.1 million for Q1 2023, and its period low was $195000.0 during Q4 2024.
  • In the last 4 years, Orchestra BioMed Holdings' Gross Profit had a median value of $812000.0 in 2025 and averaged $717066.7.
  • Within the past 5 years, the most significant YoY rise in Orchestra BioMed Holdings' Gross Profit was 15249.27% (2023), while the steepest drop was 7952.38% (2023).
  • Orchestra BioMed Holdings' Gross Profit (Quarter) stood at $1.0 million in 2022, then plummeted by 79.52% to $215000.0 in 2023, then dropped by 9.3% to $195000.0 in 2024, then surged by 316.41% to $812000.0 in 2025.
  • Its Gross Profit stands at $812000.0 for Q3 2025, versus $790000.0 for Q2 2025 and $824000.0 for Q1 2025.